[Skip to Content]
[Skip to Content Landing]
Article
September 1966

Vitiligo and Sympathectomy: The Effect of Sympathectomy and a-Melanocyte Stimulating Hormone

Author Affiliations

NEW HAVEN, CONN

From the Section of Dermatology, Department of Medicine, and the Department of Anatomy, Yale University School of Medicine, New Haven, Conn.

Arch Dermatol. 1966;94(3):269-278. doi:10.1001/archderm.1966.01600270019004
Abstract

A 29-year-old man with vitiligo was treated by sympathectomy and later by racemized α-melanin-stimulating hormone (MSH). Only a slight increase in melanogenic activity of normal skin followed sympathectomy, while the vitiligo progressed. Alpha-MSH produced darkening and melanocytic activity in normal skin, but vitiliginous areas were unaffected.

×